ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Mack, Specter Hit White House Budget Proposal For NIH.

February 18, 2000

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

In Brief: Wynder Receives ACS Award At ASCO; Brinker to Be Honored for Public Service

May 23, 1997